Page 14 - Exc News Today

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. During the quarter the strategy returned -6.0% net of fees compared to the S&P 500’s -3.3% return. As the quarter demonstrated, the markets are uncertain. In addition, you […]

DXC Technology Company (NYSE:DXC) Q2 2024 Earnings Call Transcript November 1, 2023 Operator: Thank you. Good afternoon, everybody. I’m pleased that you’re joining us for DXC Technology’s Second Quarter Fiscal Year 2024 Earnings Call. Our speakers on the call today will be Mike Salvino, Chairman, President and CEO and Rob Del Bene, our EVP and […]

Peterson Financial Group Inc. grew its position in shares of Exelon Co. (NASDAQ:EXC – Free Report) by 9.6% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 48,879 shares of the company’s stock after buying an additional 4,283 shares during the quarter. Exelon accounts […]

Exelon (NASDAQ:EXC – Free Report) had its price objective cut by Morgan Stanley from $45.00 to $42.00 in a research report released on Wednesday, Benzinga reports. They currently have an overweight rating on the stock. A number of other analysts have also commented on the company. StockNews.com began coverage on Exelon in a research note […]

Northwest Capital Management Inc purchased a new position in Exelon Co. (NASDAQ:EXC – Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 932 shares of the company’s stock, valued at approximately $38,000. A number of other institutional investors and hedge funds […]

Northwest Capital Management Inc bought a new stake in Exelon Co. (NASDAQ:EXC – Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 932 shares of the company’s stock, valued at approximately $38,000. Other hedge funds have also modified their holdings of the […]

Lakeside Advisors INC. lessened its holdings in shares of Exelon Co. (NASDAQ:EXC – Free Report) by 2.5% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 17,458 shares of the company’s stock after selling 450 shares during the period. Lakeside Advisors INC.’s holdings in Exelon were worth $711,000 […]

Shares of Exelon Co. (NASDAQ:EXC – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and seven have given a buy recommendation to […]

Exelon Co. (NASDAQ:EXC – Get Free Report) saw a large decrease in short interest in the month of September. As of September 30th, there was short interest totalling 13,270,000 shares, a decrease of 9.7% from the September 15th total of 14,700,000 shares. Based on an average daily volume of 5,310,000 shares, the days-to-cover ratio is […]

Raymond James & Associates decreased its holdings in Exelon Co. (NASDAQ:EXC – Free Report) by 50.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 356,102 shares of the company’s stock after selling 360,679 shares during the quarter. Raymond James & Associates’ holdings in […]